symbol,statement_type,period_end,line_item,value
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Treasury Shares Number,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,179109870.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,179109870.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net Debt,1531000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,2794000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,73409000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,78801000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,43265000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,73409000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Capital Lease Obligations,63000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,76070000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,76070000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,76123000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Minority Interest,53000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,76070000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,75712000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,358000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,358000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,10185000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,750000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Revenue,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,2000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,46000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Capital Lease Obligation,46000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,656000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,9435000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,1223000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,2748000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Capital Lease Obligation,17000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,2731000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,779000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Payables,3539000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Dividends Payable,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,790000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,2749000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,86308000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,33608000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,490000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,501000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,3351000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Held To Maturity Securities,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,3351000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,2661000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,2087000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Goodwill,574000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,26573000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,26573000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,2254000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,24319000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Properties,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,52700000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,3309000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Hedging Assets Current,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Inventory,7658000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Inventories,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,94000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,12466000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Gross Accounts Receivable,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,29173000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,27973000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,1200000000.0
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Equivalents,
NATCOPHARM.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Treasury Shares Number,
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,179109870.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,179109870.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net Debt,3077000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,3861000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,56600000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,62312000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,30507000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,56600000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Capital Lease Obligations,80000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,58531000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,58531000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,58531000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Minority Interest,0.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,58531000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,58173000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,44657000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,12037000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,358000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,358000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,10532000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,804000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,709000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Revenue,40000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,2000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,53000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Capital Lease Obligation,53000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,709000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,9728000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,488000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,3808000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Capital Lease Obligation,27000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,3781000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,1029000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,1029000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Payables,3037000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,328000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Dividends Payable,31000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,323000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,2355000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,69063000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,28828000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,694000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,1119000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,194000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,959000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Held To Maturity Securities,588000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,371000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,1931000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,1371000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Goodwill,560000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,24350000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-10638000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,34988000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,1373000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,503000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,18340000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,11080000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,3692000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,40235000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,2759000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Hedging Assets Current,
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,31000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,2733000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Inventory,7005000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Inventories,430000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,2731000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,1023000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,2821000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,796000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,11889000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-197000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Gross Accounts Receivable,12086000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,17781000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,17077000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,704000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Equivalents,63000000.0
NATCOPHARM.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,641000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Treasury Shares Number,87050.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,182470115.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,182557165.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net Debt,425000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,1761000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,46860000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,50482000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,23172000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,46860000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Capital Lease Obligations,17000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,48738000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,48738000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,48738000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Minority Interest,0.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,48738000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,48373000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,32923000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,14076000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,365000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,365000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,7836000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,1005000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,-42636000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,853000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Revenue,17000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,124000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,11000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Capital Lease Obligation,11000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,853000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,6831000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,546000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,1750000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Capital Lease Obligation,6000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,1744000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,169000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,169000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Payables,3113000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,337000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Dividends Payable,37000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,101000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,2638000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,56574000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,26571000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,271000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,439000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,0.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,873000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Held To Maturity Securities,514000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,359000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,1878000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,1326000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Goodwill,552000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,23034000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-9123000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,32157000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,643000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,450000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,17616000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,10593000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,2855000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,30003000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,2290000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Hedging Assets Current,0.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,47000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,2265000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Inventory,7429000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Inventories,306000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,2866000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,1293000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,2964000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,453000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,8561000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-150000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Gross Accounts Receivable,8711000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,11248000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,9929000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,1319000000.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Equivalents,0.0
NATCOPHARM.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,1319000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Treasury Shares Number,
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,182520165.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,182520165.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net Debt,3094000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,4320000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,41307000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,46841000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,17763000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,41307000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Capital Lease Obligations,115000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,42636000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,42636000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,42636000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Minority Interest,0.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,42636000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,34000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,26666000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,14089000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,365000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,365000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,8455000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,1351000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,957000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Revenue,13000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,301000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,80000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Capital Lease Obligation,80000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,957000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,7104000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,369000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,4240000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Capital Lease Obligation,35000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,4205000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,170000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,170000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Payables,1977000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,313000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Dividends Payable,37000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,9000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,1618000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,51091000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,26224000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,469000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,617000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,1044000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Held To Maturity Securities,583000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,461000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,1329000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,822000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Goodwill,507000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,23084000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-7940000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,31024000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,1295000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,556000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,16798000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,9734000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,2641000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,24867000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,3043000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Hedging Assets Current,10000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,37000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,2746000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Inventory,7620000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Inventories,328000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,2129000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,1750000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,3413000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,649000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,6206000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-422000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Gross Accounts Receivable,6628000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,7599000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,6488000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,1111000000.0
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Equivalents,
NATCOPHARM.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,1111000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Treasury Shares Number,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net Debt,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Capital Lease Obligations,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Minority Interest,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,25682000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,13926000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Pension And Other Postretirement Benefit Plans,996000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Revenue,11000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Capital Lease Obligation,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Capital Lease Obligation,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Pensionand Other Post Retirement Benefit Plans Current,128000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Payables,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,401000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Dividends Payable,37000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,429000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Held To Maturity Securities,1104000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Goodwill,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-6627000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,15013000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,8966000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,2476000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Hedging Assets Current,0.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,37000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,2271000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Inventories,311000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,1637000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,1834000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,4200000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-151000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Gross Accounts Receivable,4280000000.0
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Equivalents,
NATCOPHARM.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,258000000.0
